From 31 October 2026, Abu Dhabi's 2025 clinical cost dataset is closed. DoH says it will use that data to refine healthcare pricing, and its own FAQ puts any gap on the next owner.
DoH Circular 205/2026, dated 12 October 2026, hard-closed clinical cost data collection for Submission Year 02 (2025) on 31 October 2026. Shafafiya no longer accepts SY02-2025 submissions or amendments, and DoH accepts no further Reconciliation Reports for the year, so that it can define the dataset used for refining healthcare pricing in Abu Dhabi. DoH publishes no repricing date or method. The compliance obligation survives the close, and DoH's own FAQ places it on new owners after a change of control. For an operator, the 2025 file is now fixed; for a buyer, its status is a diligence and warranty item.
What a board member needs before the next meeting on this.
- The 2025 dataset is closed. From 31 October 2026, Circular 205/2026 disables Shafafiya for SY02-2025 cost data submissions and amendments, and DoH accepts no further Reconciliation Reports for that year.
- DoH has named the purpose, not the date. The closure lets DoH define the dataset to be used for refining healthcare pricing in Abu Dhabi. No repricing date or method is published.
- The obligation outlives the window. Clinical costing is mandatory for every direct-care facility. DoH's FAQ lists financial penalties, more audit and potential impact on licensing status for non-compliance. No penalty amount is published.
- New owners carry it. DoH's FAQ states, citing its legal opinion, that new management is responsible for compliance after a change of ownership. On our reading, SY02 filing status belongs in diligence and in the warranties.
The Department of Health in Abu Dhabi issued Circular No. 205/2026, dated 12 October 2026 and signed by its Undersecretary, to every licensed healthcare provider in the emirate (DoH Circular 205/2026). It refers back to Circular 70/2026 of 4 May 2026, which had extended the deadline for Submission Year 02 (SY02-2025) clinical cost data to 31 August 2026, and announces the formal hard closure of that collection.
From 31 October 2026, Shafafiya is disabled for all SY02-2025 cost data submissions, amendments and modifications, and DoH accepts no further Reconciliation Reports for the year (DoH Circular 205/2026). DoH gives its reason in one line: the closure lets it "finalize and define the dataset to be used for refining healthcare pricing for the Abu Dhabi healthcare market". The circular sets no repricing date and no method. What it fixes is the evidence.
The extension was the last soft deadline
A finance team used to Abu Dhabi deadlines moving would have read 31 August as one more date that could slip. The original window in the Clinical Costing Guidelines V2 ran from 1 to 30 May 2026 (DoH Clinical Costing Guidelines V2). Circular 70/2026 moved it to 31 August.
Circular 205/2026 then left 61 days, on our count, for late files and corrections before shutting the platform, and it states no reopening. The SY2 Technical Document had already limited resubmission to corrections DoH itself requests (DoH SY2 Technical Document). On our reading, a provider whose 2025 file was missing or unreconciled on 31 October now sits in the dataset as it stood that day, or not at all.
DoH HAS SAID WHAT THE DATA IS FOR
This is not a statistical return. The Abu Dhabi Clinical Costing Standard V2 (DoH/ST/FPS/ADCC/V2/2025, effective February 2026) says clinical costing provides "valuable information for pricing purposes" (DoH Clinical Costing Standard V2), and the SY2 Technical Document describes the aim as "funding and pricing policies that utilise annual Clinical Costing results" (DoH SY2 Technical Document).
DoH has not published how or when the SY02 dataset will move any price. On our reading, a provider absent from a cost dataset used to refine pricing will see its services priced on other providers' cost evidence. That is a point about influence over the outcome, not a forecast of which way any price moves.
Get the instruments that touch your licence, assessed, as they are issued. See Regulatory Watch
The compliance exposure is still open
Closing the window does not close the obligation. DoH's Clinical Costing page states that clinical costing is mandatory for every facility giving direct patient care, regardless of size, and that failure to provide data to its standards "may mean your site is considered 'non-compliant' and liable for fines" (DoH Clinical Costing).
The Standard commits DoH to an annual compliance audit and to financial sanctions for non-compliance in sections 3.6.2.2 and 4.2.3 (DoH Clinical Costing Standard V2). The FAQ lists financial penalties, increased audit and "potential impact on site licensing status", and says a Shafafiya upload without the Reconciliation Report still leaves the site non-compliant (DoH Clinical Costing FAQ v1.0). None of these documents publishes a penalty amount.
A buyer inherits the gap
The clause a deal team is most likely to miss sits in the FAQ. Asked by new owners without a full-year audit, DoH answers that, as per its legal opinion, "the new management is responsible for complying", and that the former management must hand over the data needed (DoH Clinical Costing FAQ v1.0).
On our reading, an Abu Dhabi provider bought after 31 October carries any SY02-2025 non-submission into the new ownership, with no Shafafiya route left to cure it. The same FAQ says DoH may validate unaudited figures against the facility's Federal Tax Authority submission, so the reconciliation has to agree with the tax return as well as the ledger. That belongs in the diligence request list and in the share purchase agreement.
The next submission year is the one still open
DoH's FAQ defines the submission year as the calendar year and says the Clinical Costing team communicates exact dates for each cycle (DoH Clinical Costing FAQ v1.0). On our reading, the next file covers 1 January to 31 December 2026.
The Guidelines set the Reconciliation Report deadline at no later than 31 May each year, with a signed CFO attestation (DoH Clinical Costing Guidelines V2), but no dates for the next cycle were on the Clinical Costing page when we checked on 6 November 2026. The Standard lists November 2026 as its revision date (DoH Clinical Costing Standard V2), so the rulebook may change before the window opens.
Four questions now the 2025 cost dataset is closed
- For each licensed facility, do we hold the Shafafiya acknowledgement for SY02-2025 cost data and evidence that the CFO-signed Reconciliation Report reached DoH before 31 October 2026?
- If any facility missed the close, what have we told the DoH Clinical Costing team in writing, and what does our file show?
- Is the 2026 general ledger mapped to the Standard V2 cost centres before year-end close, or will that work start after the audit?
- In any Abu Dhabi acquisition, does the share purchase agreement carry a warranty on clinical costing submissions and a specific indemnity if one was missed?
The Monday work is specific. Ask the CFO for the Shafafiya acknowledgement and the sent Reconciliation Report for every licensed facility for SY02-2025, with dates. Where one is missing, write to the DoH Clinical Costing team now and keep the reply; the circular offers no reopening, but the written record is what an auditor and a buyer will ask for.
Map the 2026 general ledger to the Standard's cost centres before the year-end close, not after the audit. On a live deal, add the SY02 filing to the request list. Building a costing process a CFO can sign and DoH can audit is the work of our operational excellence practice.
This brief covers one instrument. The UAE healthcare regulatory tracker carries the full set — DoH, DHA, EDE and the other emirates — with what each one changes and when it takes effect.
Subscribe
The UAE healthcare regulatory briefing
What changed, what it reprices, and the instrument to read. Every second Tuesday. No pitches.
One email a fortnight. Unsubscribe from any of them.